NA-Semax Atomizer
Acetylated Semax analog delivered intranasally for nootropic and neuroplasticity research

N-Acetyl Semax is an acetylated version of Semax, an ACTH-derived peptide, modified for better absorption and a longer window of activity than the unmodified form. Research interest centers on BDNF elevation, neuroplasticity, dopaminergic and serotonergic modulation, and cognitive performance. The atomizer format delivers it as a nasal spray, so dosing is consistent and needle-free.
- Typical dose
- 100 mcg per nostril (2 sprays each), daily for 4 weeks then 2-3 weeks off
- Half-life
- Extended relative to unmodified Semax due to N-terminal acetylation
- Administration
- Intranasal (atomizer spray)
- Research status
- Preclinical / Research Use Only
What Is N-Acetyl Semax?
N-Acetyl Semax (NAS) is a lab-made peptide built on the Semax scaffold, which itself comes from a short fragment of adrenocorticotropic hormone (ACTH). Attaching an acetyl group to the parent molecule slows its breakdown, so the compound stays active longer and is absorbed more efficiently than plain Semax. It is one of the most closely watched nootropic peptides in research settings, largely because of its capacity to raise brain-derived neurotrophic factor (BDNF) — a key driver of neuroplasticity and durable cognitive function. NAS also touches dopamine and serotonin signaling, and the atomizer format delivers it as a nasal spray for steady dosing without needles.
Mechanisms of Action
BDNF elevation — research on Semax reports marked increases in brain-derived neurotrophic factor, which underpins synaptic remodeling and the growth of new neural connections.
Dopamine and serotonin signaling is modulated through neuropeptide systems tied to mood, drive, attention, and reward.
Antioxidant defense in neural tissue, with lower oxidative stress markers observed in neurons — a plausible route to longer-term neuroprotection.
Cholinergic support — stronger acetylcholine signaling, which lines up with the memory-consolidation and attention effects described in the literature.
Direct nose-to-brain route — intranasal dosing sidesteps much of the blood-brain barrier, putting the peptide closer to target brain regions than systemic administration.
Benefits
Sharper cognition — recall, focus, mental clarity, and processing speed are the most consistently described effects, making NAS one of the more dependable nootropic peptides for daily mental output.
Greater neuroplasticity as a downstream result of BDNF signaling, helping the brain learn, adapt, and reorganize during demanding cognitive periods.
Steadier mood, attributed to serotonergic and dopaminergic activity that supports a more even emotional baseline.
Reduced anxiety in early findings, though this sits well behind the cognitive effects in both strength and evidence.
More alertness and drive, frequently described as sustained mental stamina and productivity across the day.
Long-horizon brain health through antioxidant and anti-inflammatory activity in neural tissue.
Dosing
Dose Level | Dose | Frequency |
|---|---|---|
Standard | 100 mcg per nostril (2 sprays each) | Daily for 4 weeks, then 2–3 weeks off |
Delivery is intranasal using the supplied atomizer. Run a four-week block, then pause for two to three weeks so receptor sensitivity resets rather than dulling over time. A choline source alongside the peptide is the simplest way to head off headaches.
Note: Keep dosing to earlier in the day — the lift in energy and alertness can push into the evening and interfere with sleep. Should headaches appear, adding choline generally clears them up.
Safety Profile
Headache is the side effect reported most often. It tracks with cholinergic activity and is usually avoided outright by stacking CDP Choline or Alpha GPC.
Nasal irritation can build up with repeated spraying; good technique and alternating nostrils keep it minimal.
Disrupted sleep shows up mainly when dosing runs late in the day, a byproduct of the compound's alertness and energy effects.
Stacking
Nootropic pairing
NA-Semax
Alpha GPC 600 mg
Uridine 400 mg
Cognition pairing
NA-Semax
Selank
NAD+
Neuroprotection pairing
NA-Semax
SS-31
MOTS-c
Citations
Shadrina, M. I., et al. Neuroprotective and neuroplastic effects of Semax in experimental models. PubMed. https://pubmed.ncbi.nlm.nih.gov/17313274/
Disclaimer: The information provided is intended solely for educational purposes and should not be considered a replacement for professional medical advice. All compounds referenced are not for human consumption.
Where to source
Optimum Formula10% Off